GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aqua Bio Technology ASA (OSL:ABTEC) » Definitions » Operating Income

Aqua Bio Technology ASA (OSL:ABTEC) Operating Income : kr-12.61 Mil (TTM As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Aqua Bio Technology ASA Operating Income?

Aqua Bio Technology ASA's Operating Income for the six months ended in Jun. 2023 was kr-8.04 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2023 was kr-12.61 Mil.

Warning Sign:

Aqua Bio Technology ASA has never been profitable in the past 3 years. It lost money every year.

Operating Margin % is calculated as Operating Income divided by its Revenue. Aqua Bio Technology ASA's Operating Income for the six months ended in Jun. 2023 was kr-8.04 Mil. Aqua Bio Technology ASA's Revenue for the six months ended in Jun. 2023 was kr7.02 Mil. Therefore, Aqua Bio Technology ASA's Operating Margin % for the quarter that ended in Jun. 2023 was -114.51%.

Good Sign:

Aqua Bio Technology ASA operating margin is expanding. Margin expansion is usually a good sign.

Aqua Bio Technology ASA's 5-Year average Growth Rate for Operating Margin % was 23.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Jun. 2023 was -20.69%. Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 721.99%.


Aqua Bio Technology ASA Operating Income Historical Data

The historical data trend for Aqua Bio Technology ASA's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aqua Bio Technology ASA Operating Income Chart

Aqua Bio Technology ASA Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.37 -13.13 -16.11 -17.86 -16.37

Aqua Bio Technology ASA Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.94 -8.92 -11.80 -4.56 -8.04

Aqua Bio Technology ASA Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-12.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aqua Bio Technology ASA  (OSL:ABTEC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

ROC % (Q: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Jun. 2023 ))/ count )
=-16.086 * ( 1 - 1.13% )/( (74.571 + 79.136)/ 2 )
=-15.9042282/76.8535
=-20.69 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2022  Q: Jun. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=14.198/( ( (0.265 + max(1.968, 0)) + (1.7 + max(-1.473, 0)) )/ 2 )
=14.198/( ( 2.233 + 1.7 )/ 2 )
=14.198/1.9665
=721.99 %

where Working Capital is:

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.634 + 8.305 + 0.617) - (4.686 + 0 + 3.902)
=1.968

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.36 + 7.621 + 0.422) - (10.028 + 0 + 1.848)
=-1.473

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Aqua Bio Technology ASA's Operating Margin % for the quarter that ended in Jun. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-8.043/7.024
=-114.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Aqua Bio Technology ASA Operating Income Related Terms

Thank you for viewing the detailed overview of Aqua Bio Technology ASA's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Aqua Bio Technology ASA (OSL:ABTEC) Business Description

Traded in Other Exchanges
Address
Thormohlensgate 55, Bergen, NOR, 5008
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.

Aqua Bio Technology ASA (OSL:ABTEC) Headlines

No Headlines